Suppr超能文献

维生素 B6 可提高顺铂诱导的细胞死亡的免疫原性。

Vitamin B6 improves the immunogenicity of cisplatin-induced cell death.

机构信息

Equipe 11 labelisée par la Ligue Nationale contre le cancer; Centre de Recherche des Cordeliers ; Paris, France ; Université Paris Descartes/Paris 5 ; Sorbonne Paris Cité , Paris, France ; INSERM U1138; Paris, France ; Gustave Roussy Comprehensive Cancer Center ; Villejuif, France.

Equipe 11 labelisée par la Ligue Nationale contre le cancer; Centre de Recherche des Cordeliers ; Paris, France ; Université Paris Descartes/Paris 5 ; Sorbonne Paris Cité , Paris, France ; INSERM U1138; Paris, France ; Metabolomics and Cell Biology platforms; Gustave Roussy Comprehensive Cancer Center ; Villejuif, France ; Pôle de Biologie, Hôpital Européen Georges Pompidou ; AP-HP ; Paris, France.

出版信息

Oncoimmunology. 2014 Dec 13;3(9):e955685. doi: 10.4161/21624011.2014.955685. eCollection 2014 Oct.

Abstract

We have recently demonstrated that pyridoxine, a precursor of vitamin B6, increases the immunogenicity of non-small cell lung carcinoma (NSCLC) cells succumbing to cisplatin (cis-diamminedichloroplatinum(II), CDDP). Accordingly, pyridoxine promoted the antineoplastic activity of CDDP in NSCLC-bearing mice only in the presence of an intact immune system. These findings may have implications for the development of novel strategies to circumvent CDDP resistance.

摘要

我们最近证实,维生素 B6 的前体吡哆醇可提高顺铂(顺式-二氨二氯铂(II),CDDP)作用下的非小细胞肺癌(NSCLC)细胞的免疫原性。因此,只有在免疫系统完整的情况下,吡哆醇才能促进 CDDP 在荷瘤 NSCLC 小鼠中的抗肿瘤活性。这些发现可能对开发克服 CDDP 耐药性的新策略具有重要意义。

相似文献

1
Vitamin B6 improves the immunogenicity of cisplatin-induced cell death.
Oncoimmunology. 2014 Dec 13;3(9):e955685. doi: 10.4161/21624011.2014.955685. eCollection 2014 Oct.
2
Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer.
Oncogene. 2015 Jun 4;34(23):3053-62. doi: 10.1038/onc.2014.234. Epub 2014 Jul 28.
3
Vitamin B6 metabolism influences the intracellular accumulation of cisplatin.
Cell Cycle. 2013 Feb 1;12(3):417-21. doi: 10.4161/cc.23275. Epub 2012 Feb 1.
4
Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses.
Oncogene. 2013 Oct 17;32(42):4995-5004. doi: 10.1038/onc.2012.623. Epub 2013 Jan 21.
5
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.
Oncogene. 2011 Mar 10;30(10):1147-58. doi: 10.1038/onc.2010.500. Epub 2010 Dec 13.
7
Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.
Cancer Biol Ther. 2016 May 3;17(5):515-25. doi: 10.1080/15384047.2015.1095405. Epub 2015 Oct 22.
9
Vitamin B-6-Induced Neuropathy: Exploring the Mechanisms of Pyridoxine Toxicity.
Adv Nutr. 2021 Oct 1;12(5):1911-1929. doi: 10.1093/advances/nmab033.
10
Elevated pressure, a novel cancer therapeutic tool for sensitizing cisplatin-mediated apoptosis in A549.
Biochem Biophys Res Commun. 2010 Aug 13;399(1):91-7. doi: 10.1016/j.bbrc.2010.07.047. Epub 2010 Jul 17.

引用本文的文献

3
Science-Driven Nutritional Interventions for the Prevention and Treatment of Cancer.
Cancer Discov. 2022 Oct 5;12(10):2258-2279. doi: 10.1158/2159-8290.CD-22-0504.
6
Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response.
Int J Mol Sci. 2018 Sep 26;19(10):2922. doi: 10.3390/ijms19102922.
7
The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.
Oncol Lett. 2018 May;15(5):6799-6805. doi: 10.3892/ol.2018.8215. Epub 2018 Mar 8.
8
Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors.
Oncotarget. 2017 Jan 24;8(4):5686-5691. doi: 10.18632/oncotarget.13892.
9
Autophagy, autophagy-associated adaptive immune responses and its role in hematologic malignancies.
Oncotarget. 2017 Feb 14;8(7):12374-12388. doi: 10.18632/oncotarget.13583.
10
Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer.
Oncoimmunology. 2016 Jun 9;5(7):e1177692. doi: 10.1080/2162402X.2016.1177692. eCollection 2016 Jul.

本文引用的文献

1
Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer.
Oncogene. 2015 Jun 4;34(23):3053-62. doi: 10.1038/onc.2014.234. Epub 2014 Jul 28.
2
Systems biology of cisplatin resistance: past, present and future.
Cell Death Dis. 2014 May 29;5(5):e1257. doi: 10.1038/cddis.2013.428.
3
Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance.
Immunity. 2013 Jul 25;39(1):74-88. doi: 10.1016/j.immuni.2013.06.014.
4
Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses.
Oncogene. 2013 Oct 17;32(42):4995-5004. doi: 10.1038/onc.2012.623. Epub 2013 Jan 21.
5
Vitamin B6 metabolism influences the intracellular accumulation of cisplatin.
Cell Cycle. 2013 Feb 1;12(3):417-21. doi: 10.4161/cc.23275. Epub 2012 Feb 1.
6
Immunogenic cell death in cancer therapy.
Annu Rev Immunol. 2013;31:51-72. doi: 10.1146/annurev-immunol-032712-100008. Epub 2012 Nov 12.
7
Prognostic impact of vitamin B6 metabolism in lung cancer.
Cell Rep. 2012 Aug 30;2(2):257-69. doi: 10.1016/j.celrep.2012.06.017. Epub 2012 Jul 26.
8
Molecular mechanisms of cisplatin resistance.
Oncogene. 2012 Apr 12;31(15):1869-83. doi: 10.1038/onc.2011.384. Epub 2011 Sep 5.
9
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.
Oncogene. 2011 Mar 10;30(10):1147-58. doi: 10.1038/onc.2010.500. Epub 2010 Dec 13.
10
The resurgence of platinum-based cancer chemotherapy.
Nat Rev Cancer. 2007 Aug;7(8):573-84. doi: 10.1038/nrc2167. Epub 2007 Jul 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验